Business
BioElectronics "Try It and Tell Us" Facebook Social Media Program Builds Momentum and User Testimonials
BioElectronics "Try It and Tell Us" Facebook Social Media Program Builds Momentum and User Testimonials.
About this update from Bioelectronics Corp.
[{"type":"text","content":"\n\n\n\nBioElectronics \"Try It and Tell Us\" Facebook Social Media Program Builds Momentum and User Testimonials\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nBioElectronics \"Try It and Tell Us\" Facebook Social Media Program Builds Momentum and User Testimonials\nUK Consumers Report ActiPatch® Therapy Reduces Pain, Including Fibromyalgia, Without Drugs\nPR Newswire\nFREDERICK, Md., June 30, 2014\n\n\n\nFREDERICK, Md., June 30, 2014 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced drug-free consumer medical devices, today announced positive early feedback from its \"Try It and Tell Us\" social media program in the United Kingdom that has attracted thousands of followers. The company's Facebook-based program offers U.K. and Irish consumers free trial devices, delivering a week of therapy, and then surveys them about their experience including self-reported pain personal experience.\n\nThe company reported that its \"Try It & Tell Us\" sample program for United Kingdom and Ireland residents is working well with thousands of 7-day ActiPatch® Therapy samples already shipped.  For first-hand testimonials from the consumers visit www.actipatch.com/testimonials or www.facebook.com/ActiPatch to see what people in the UK and Ireland are saying about the product. People in London can see the product at \"The Back Pain Show\" on July 4-6, 2014 in Strand B47, Olympia Grad Hall, W14-8, London. \n\n\"We've just begun tabulating the feedback, but it is very positive. Across the board ActiPatch Therapy reduced pain without drugs,\" said Ian Rawe, Ph.D., Director of Clinical Research at BioElectronics Corporation. \"While this is only an informal survey, it's real world experience and we are beginning to see the benefits of ActiPatch Therapy with consumers suffering from long term chronic pain.  \n\n\"The data exposed another important indication, fibromyalgia, a significant medical issue that causes suffers substantial pain that we have not previously studied in a formal clini...